These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14612147)

  • 21. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter.
    Chen N; Appell M; Berfield JL; Reith ME
    Eur J Pharmacol; 2003 Oct; 478(2-3):89-95. PubMed ID: 14575792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and dopamine transporter binding affinities of 3alpha-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes.
    Bradley AL; Izenwasser S; Wade D; Klein-Stevens C; Zhu N; Trudell ML
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2387-90. PubMed ID: 12161139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry.
    Greco PG; Garris PA
    Eur J Pharmacol; 2003 Oct; 479(1-3):117-25. PubMed ID: 14612143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
    Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
    J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors.
    Czoty PW; Ramanathan CR; Mutschler NH; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2004 Nov; 311(2):720-7. PubMed ID: 15240827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cocaine induction of dopamine transporter trafficking to the plasma membrane.
    Little KY; Elmer LW; Zhong H; Scheys JO; Zhang L
    Mol Pharmacol; 2002 Feb; 61(2):436-45. PubMed ID: 11809869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis.
    Orset C; Parrot S; Sauvinet V; Cottet-Emard JM; Bérod A; Pequignot JM; Denoroy L
    Neurochem Int; 2005 Jun; 46(8):623-33. PubMed ID: 15863240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationship studies of highly selective inhibitors of the dopamine transporter: N-benzylpiperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine.
    Greiner E; Prisinzano T; Johnson EM; Dersch CM; Marcus J; Partilla JS; Rothman RB; Jacobson AE; Rice KC
    J Med Chem; 2003 Apr; 46(8):1465-9. PubMed ID: 12672246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems.
    Zahniser NR; Doolen S
    Pharmacol Ther; 2001 Oct; 92(1):21-55. PubMed ID: 11750035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
    Sidhu A; Wersinger C; Vernier P
    FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal heptachlor exposure increases expression of presynaptic dopaminergic markers in mouse striatum.
    Caudle WM; Richardson JR; Wang M; Miller GW
    Neurotoxicology; 2005 Aug; 26(4):721-728. PubMed ID: 16112329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
    Schenk JO; George SE; Schumacher PD
    Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
    Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
    J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
    Park SU; Ferrer JV; Javitch JA; Kuhn DM
    J Neurosci; 2002 Jun; 22(11):4399-405. PubMed ID: 12040046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine transporter in vitro binding and in vivo imaging in the brain.
    Bergström KA; Tupala E; Tiihonen J
    Pharmacol Toxicol; 2001 Jun; 88(6):287-93. PubMed ID: 11453367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates.
    Schmitt KC; Rothman RB; Reith ME
    J Pharmacol Exp Ther; 2013 Jul; 346(1):2-10. PubMed ID: 23568856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.